In several malignant tumors, including ovarian carcinoma, cholangiocarcinoma, mesothelioma, and breast cancer, GPC3 is down-regulated as a result of hypermethylation of the GPC3 promoter [48, 49, 52, 53]. Here, GPC3 is linked to ovarian carcinoma.